Literature DB >> 8306028

Immunophenotyping of eosinophils recovered from blood and BAL of allergic asthmatics.

H J Mengelers1, T Maikoe, L Brinkman, B Hooibrink, J W Lammers, L Koenderman.   

Abstract

Studies of bronchoalveolar lavage (BAL) fluid from patients with allergic asthma have demonstrated active migration of eosinophils into the bronchial lumen after allergen challenge. The mechanisms mediating this eosinophil infiltration and cell activation are largely unexplained. The expression of several cell-surface molecules was measured on eosinophils derived from blood and BAL fluid 4 h after an allergen-induced early asthmatic reaction in order to find indications for a role of these molecules during extravasation to and activation in the bronchial compartment. Nine patients with allergic asthma participated in the study. An eosinophil-specific, high-depolarization signal enabled us to measure expression on eosinophils in a fluorescence activated cell sorter (FACS) analysis without isolation of these cells. Eosinophils recovered from BAL showed a different phenotype than blood eosinophils; upregulation of CR-3, p150/95, CD67, and CD63, and downregulation of L-selectin indicate that the cells are activated in terms of degranulation. Up-regulation of intercellular adhesion molecule-1 (ICAM-1), LFA-3, and human leukocyte antigen II (HLA-II) might enable cell-cell contact between T-lymphocytes and eosinophils, probably leading to immunomodulation and cell activation. The finding that eosinophils in BAL are activated and can interact with T cells is further evidence for the proinflammatory role of these cells in allergic asthma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8306028     DOI: 10.1164/ajrccm.149.2.8306028

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  18 in total

Review 1.  Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?

Authors:  Taku Kambayashi; Terri M Laufer
Journal:  Nat Rev Immunol       Date:  2014-10-17       Impact factor: 53.106

2.  Systemic eosinophil response induced by respiratory syncytial virus.

Authors:  C A Lindemans; J L L Kimpen; B Luijk; J Heidema; D Kanters; C K van der Ent; L Koenderman
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

Review 3.  Activation states of blood eosinophils in asthma.

Authors:  M W Johansson
Journal:  Clin Exp Allergy       Date:  2014-04       Impact factor: 5.018

4.  Lymph node trafficking and antigen presentation by endobronchial eosinophils.

Authors:  H Z Shi; A Humbles; C Gerard; Z Jin; P F Weller
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

5.  Intracellular signaling mechanisms regulating the activation of human eosinophils by the novel Th2 cytokine IL-33: implications for allergic inflammation.

Authors:  Joyce Y S Chow; Chun K Wong; Phyllis F Y Cheung; Christopher W K Lam
Journal:  Cell Mol Immunol       Date:  2009-12-23       Impact factor: 11.530

Review 6.  Eosinophils: multifaceted biological properties and roles in health and disease.

Authors:  Hirohito Kita
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

Review 7.  Eosinophils: Nemeses of Pulmonary Pathogens?

Authors:  Kim S LeMessurier; Amali E Samarasinghe
Journal:  Curr Allergy Asthma Rep       Date:  2019-06-19       Impact factor: 4.806

8.  Allergy, asthma, and inflammation: which inflammatory cell type is more important?

Authors:  Redwan Moqbel; Solomon O Odemuyiwa
Journal:  Allergy Asthma Clin Immunol       Date:  2008-12-15       Impact factor: 3.406

9.  Airway eosinophils: allergic inflammation recruited professional antigen-presenting cells.

Authors:  Hai-Bin Wang; Ionita Ghiran; Klaus Matthaei; Peter F Weller
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

10.  Up-regulation and activation of eosinophil integrins in blood and airway after segmental lung antigen challenge.

Authors:  Mats W Johansson; Elizabeth A B Kelly; William W Busse; Nizar N Jarjour; Deane F Mosher
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.